Pharmaceutical & Biotech Project Starts to Double in 2011
Industrial Info Resources” 2011 Pharmaceutical & Biotech Industry Outlook report projects capital expenditures of $18 billion this year in North America, up from the actual $9 billion in 2010 project starts. As of March 24, 2011, Industrial Info reports the actual reported count for projects scheduled to begin construction during 2011 in North America is 757. These projects are measured on the scheduled kick-off date and are valued at $1 million and greater.
The Industrial Info report includes the following information:
Company/Sector Data
• Top 20 Pharmaceutical Company Rankings by 2009 Sales Revenue
• Top 10 Biotech Company Rankings by 2009 Sale Revenue
• Top 5 Generic Manufacturers by 2009 Sales Revenue
• Top 15 Pharmaceutical Stock 2010 Performance
• Top 10 Biopharmaceutical Stock 2010 Performance
• Major 2010 Layoff Announcements
• National Health Expenditures 2009
• PhRMA Member Companies
• Drug Industry Employment statistics for the United States
Product Performance Data
• Top 10 R&D Spending by Company 2009
• Top 10 Therapeutic Classes by Sales 2005-2009
• Top 20 Pharmaceutical Drugs by Sales 2009
• Top 10 Biotech Drugs by Sales 2009
• Top 10 Generic Drugs by Prescription Count 2009
• Top Drugs Losing Patent Protection 2011-2012
• Top Selling Vaccines 2007 – 2009
• Top 10 Industry Mergers
For more information on Industrial Info”s “2011 Pharmaceutical & Biotech Industry Outlook,” click here.
